Intestinal histological findings in patients with spondyloarthritis: a study of the relationship with disease...

Area of Science:

• Immunology
• Gastroenterology
• Rheumatology

Background:

• The link between the gut microbiome and spondyloarthritis (SpA) is an emerging area of research.
• Subclinical bowel inflammation is frequently observed in SpA patients, often asymptomatic.
• The gut-joint axis hypothesis proposes that gut-derived immune cells contribute to SpA.

Purpose of the Study:

• To explore the role of the intestinal microbiome in the development of spondyloarthritis (SpA).
• To investigate the significance of subclinical bowel inflammation in SpA etiology.
• To examine the evidence supporting the gut-joint axis hypothesis in SpA.

Main Methods:

• Review of current literature on the gut microbiome, bowel inflammation, and SpA.
• Analysis of findings from ileocolonoscopy in SpA patient cohorts.
• Examination of immunological studies investigating cell origins in SpA.

Main Results:

• A significant proportion of SpA patients (around 65%) exhibit asymptomatic ileocolonic inflammation.
• The intestinal microbiome composition may influence SpA development.
• Immune cells, including monocytes and T cells, implicated in joint inflammation in SpA may originate from the gut.

Conclusions:

• The intestinal microbiome and subclinical bowel inflammation are critical factors in spondyloarthritis pathogenesis.
• The gut-joint axis provides a framework for understanding the connection between gut health and SpA.
• Further research into gut-targeted therapies for SpA is warranted.